Calculus Capital

Calculus Capital Launches Zero Initial Fee VCT Offer
Jul 29, 2019

Enterprise Investment Scheme and Venture Capital Trust specialist Calculus Capital is to waive initial fees on its new VCT until the end of the year. The firm explained that most providers charge “promoter fees” of between 3% and 5% – Calculus will waive this fee if a subscription is made before the end of the year. Calculus launched its first VCT over a decade ago and it told GBI Magazine that its funds have consistently hit their dividend targets. The new Calculus VCT fund, which invests alongside Calculus EIS funds, is aiming to deliver an annual dividend of 4.5% from summer 2019. VCT investments attract 30% income tax relief if held for five years. Dividends are tax free too, and there is no capital gains tax on the sale of shares. For more information and to read the full article, please <a href="https://www.gbinvestments.co.uk/article/eis-and-vct-specialist-calculus-capital/">click here</a>

Enterprise Investment Scheme and Venture Capital Trust specialist Calculus Capital is to waive initial fees on its new VCT until the end of the year. The fir read more
Venture Capital Trusts or Enterprise Investment Scheme – Which is Right for You?
Jul 29, 2019

In the past 10 years the VCT and EIS markets have doubled in size as awareness of them has grown and the amount investors can save into pensions has been squeezed. Both schemes were designed with the intention of directing private risk capital into small UK businesses and helping the British economy grow, so might be considered patriotic investments. Both offer attractive tax benefits and low correlation to mainstream, large-cap markets (like the FTSE 100), so can be attractive to investors who are looking to reduce tax bills, build diversification into their portfolios and are comfortable with the risks involved. VCTs and EISs are particularly useful for higher-rate taxpayers looking to reduce their income tax bill. They can help investors who want to save for retirement tax efficiently but have used all their pension contribution allowances or who may be close to breaching their pensions lifetime allowance. Despite these similarities, they each have some distinct features that may make one more suited than the other for individual investors. <a href="https://www.whatinvestment.co.uk/venture-capital-trusts-or-enterprise-investment-scheme-which-is-right-for-you-2615719/">For more information and to read the full article, please click here</a>

In the past 10 years the VCT and EIS markets have doubled in size as awareness of them has grown and the amount investors can save into pensions has been squeez read more
2% off the initial fee for Calculus VCT – limited time only!
Mar 18, 2019

Calculus Capital is to offer a flash discount of 2% off the initial fee, making it one of the most attractive in the current marketplace. Calculus will take 2% off their promoters fee, which is usually 5% for those applying direct and 3% for those applying through a professional adviser, providing a subscription is made by 3 April 2019. <a href="https://www.calculuscapital.com/2-off-the-initial-fee-for-calculus-vct-limited-time-only/">For more information and full article, click here</a>

Calculus Capital is to offer a flash discount of 2% off the initial fee, making it one of the most attractive in the current marketplace. Calculus will take 2% read more
EIS has cost the government £3bn in tax relief, so why has it become more generous?
Feb 27, 2019

The enterprise investment scheme (EIS) celebrates its silver jubilee this year. Announced by the then chancellor Ken Clarke in the Autumn Budget in 1993, the scheme was launched at the beginning of 1994. The benefits of the EIS have remained generous – in fact, they’ve become more generous. Until April 2011, the up-front tax relief was 20 per cent. Today it is 30 per cent. Those aren’t the only benefits: your investments are free of capital gains tax, you get loss relief, and your pot becomes inheritance tax free

The enterprise investment scheme (EIS) celebrates its silver jubilee this year. Announced by the then chancellor Ken Clarke in the Autumn Budget in 1993, the sc read more
Investing for a better world
Feb 14, 2019

You might argue that the most attractive thing about EIS and VCT funds is the raft of tax benefits that accompany them. They certainly are generous – both are CGT-free and offer 30% income tax relief. But focus too much on the tax and you might miss one of their most rewarding and exciting aspects. Those tax benefits exist because investors are putting their capital at risk. Small unquoted companies by their nature are higher risk than their large listed counterparts, however their potential to affect transformative change to an industry and provide impressive investor returns has long been proven. <a href="https://www.calculuscapital.com/investing-for-a-better-world/">For more information and full article, click here</a>

You might argue that the most attractive thing about EIS and VCT funds is the raft of tax benefits that accompany them. They certainly are generous read more
Venture Capital Trusts or Enterprise Investment Scheme – Which is Right for You?
Feb 14, 2019

In the past 10 years the VCT and EIS markets have doubled in size as awareness of them has grown and the amount investors can save into pensions has been squeezed. Both schemes were designed with the intention of directing private risk capital into small UK businesses and helping the British economy grow, so might be considered patriotic investments. Both offer attractive tax benefits and low correlation to mainstream, large-cap markets (like the FTSE 100), so can be attractive to investors who are looking to reduce tax bills, build diversification into their portfolios and are comfortable with the risks involved. VCTs and EISs are particularly useful for higher-rate taxpayers looking to reduce their income tax bill. They can help investors who want to save for retirement tax efficiently but have used all their pension contribution allowances or who may be close to breaching their pensions lifetime allowance. Despite these similarities, they each have some distinct features that may make one more suited than the other for individual investors. <a href="https://www.whatinvestment.co.uk/venture-capital-trusts-or-enterprise-investment-scheme-which-is-right-for-you-2615719/">For more information and to read the full article, please click here</a>

In the past 10 years the VCT and EIS markets have doubled in size as awareness of them has grown and the amount investors can save into pensions has been squeez read more
Calculus VCT appoints new chair creating all-female board
Feb 05, 2019

The board of the Calculus Venture Capital Trust has appointed Jan Ward as its chair when Michael O'Higgins steps down from the role later this year. Ward will become a non-executive director of the Calculus VCT from 1 March and will chair the board after the AGM, which is currently scheduled for 4 July. Ward is a mechanical engineer and the founder/CEO of global nickel supplier Corrotherm International. She has previously been a director of Woman in Business International and was named the UK's most inspirational female entrepreneur in 2009, before receiving a CBE for services to business in 2015. For more information and to read the full article, please <a href="https://www.investmentweek.co.uk/investment-week/news/3070431/calculus-vct-appoints-new-chair-creating-all-female-board?utm_medium=email&utm_content=&utm_campaign=IW.Daily_RL.EU.A.U&utm_source=IW.DCM.Editors_Updates&utm_term=GROWTH%20INVEST&im_company=GROWTH%20INVEST&utm_medium=email&utm_term=&im_edp=6257785-beb0ebdbc2f99563%26campaignname%3DIW.Daily_RL.EU.A.U">click here</a>

The board of the Calculus Venture Capital Trust has appointed Jan Ward as its chair when Michael O'Higgins steps down from the role later this year. Ward wil read more
Calculus Capital invests £2.5m in Essentia Analytics
Jan 28, 2019

EIS & VCT specialist Calculus Capital has invested £2.5m in fintech company Essentia Analytics (see photo), a leading provider of behavioural data analytics and consulting for professional investors. The investment by Calculus will be used to further develop Essentia’s services as it scales its client base of investment management institutions around the world. The firm’s Essentia Insight service – which is used by clients including active fund managers, chief investment officers, asset allocators and wealth managers – provides a continuous data-driven feedback loop, similar to those used by athletes. For more information and to read the full article, please <a href="https://www.angelnews.co.uk/blog/eis-seis/calculus-capital-invests-25m-in-essentia-analytics/">click here</a>

EIS & VCT specialist Calculus Capital has invested £2.5m in fintech company Essentia Analytics (see photo), a leading provider of behavioural data analytic read more
Calculus Capital invests £2.5m in Essentia Analytics
Jan 28, 2019

EIS & VCT specialist <a href="https://www.calculuscapital.com/">Calculus Capital</a> has invested £2.5m in fintech company Essentia Analytics (see photo), a leading provider of behavioural data analytics and consulting for professional investors. The investment by Calculus will be used to further develop Essentia’s services as it scales its client base of investment management institutions around the world. The firm’s Essentia Insight service – which is used by clients including active fund managers, chief investment officers, asset allocators and wealth managers – provides a continuous data-driven feedback loop, similar to those used by athletes. For more information and to read the full article, please <a href="https://www.angelnews.co.uk/blog/eis-seis/calculus-capital-invests-25m-in-essentia-analytics/">click here</a>

EIS & VCT specialist Calculus Capital has invested £2.5m in fintech company Essentia Analytics (see photo), read more
Calculus Capital extends zero initial fee VCT offer
Jan 23, 2019

EIS and VCT specialist Calculus Capital has extended the zero initial fees offer on its new VCT until the middle of February. The initial offer waived the industry standard promoter fees of between 3% and 5% to the end of 2018, but it is now extending that deal to subscriptions made before February 15th. The firm told GBI Magazine that the decision follows requests from advisers grappling with client tax returns and investors waiting for bonus cheques. For more information and to read the full article, please <a href="https://www.gbinvestments.co.uk/article/calculus-capital-2/">click here</a>

EIS and VCT specialist Calculus Capital has extended the zero initial fees offer on its new VCT until the middle of February. The initial offer waived the in read more
Calculus Capital Launches Zero Initial Fee VCT Offer
Nov 28, 2018

Enterprise Investment Scheme and Venture Capital Trust specialist Calculus Capital is to waive initial fees on its new VCT until the end of the year. The firm explained that most providers charge “promoter fees” of between 3% and 5% – Calculus will waive this fee if a subscription is made before the end of the year. Calculus launched its first VCT over a decade ago and it told GBI Magazine that its funds have consistently hit their dividend targets. The new Calculus VCT fund, which invests alongside Calculus EIS funds, is aiming to deliver an annual dividend of 4.5% from summer 2019. VCT investments attract 30% income tax relief if held for five years. Dividends are tax free too, and there is no capital gains tax on the sale of shares. For more information and to read the full article, please <a href="https://www.gbinvestments.co.uk/article/eis-and-vct-specialist-calculus-capital/">click here</a>

Enterprise Investment Scheme and Venture Capital Trust specialist Calculus Capital is to waive initial fees on its new VCT until the end of the year. The fir read more
John Glencross: Don't Mourn Death of Asset-Backed EIS Offerings
Mar 28, 2018

The US is usually seen as offering the global benchmark for innovation but, as John Glencross illustrates, the UK is now trumping the world's largest economy on several counts. Some advisers may be mourning the fact the door has now closed on asset-backed Enterprise Investment Scheme (EIS) offerings even if it should come as no surprise the government withdrew tax relief for low-risk investment. Nevertheless, this is a particularly exciting time for UK growth investing. The US is usually seen as offering the global benchmark for innovation and entrepreneurship, against which all other countries are measured - and usually fail. But the UK is now trumping the US on several counts. Between 2006 and 2016, the number of new businesses ‘born' in the UK rose by 62% - up from 256,000 to 414,000 a year. That is 45 new businesses every hour. By contrast, according to the latest figures available, the number of business births in the US fell by 25%, from 558,000 to 414,000 annually, between 2006 and 2015. This means the UK launched exactly the same number of new businesses in 2016 as the US did in 2015. Bear in mind, however, that our population is around 66 million compared to their 323 million. Admittedly, not all these new business owners are budding James Dysons but OECD numbers suggest a healthy proportion of new UK businesses are genuine start-ups. The UK leads the OECD nations in terms of the number of employer business births - though American start-ups still beat everyone in terms of job creation. The US and the UK are almost neck and neck in the World Bank ‘Doing Business' ratings on ‘ease of doing business' - the UK is seventh and the US sixth. When it comes to starting a business, however, the UK is 14th and the US 49th. Since 2015, there has been a 40%-plus decline in the number of angel and seed deals closed in the US, but late-stage deal values are at record highs. And there lies the challenge for both economies. In my opinion, Britain is a better place to start a business - and EIS investments are helping to create that environment, with almost £16.2bn raised for 26,355 individual companies since the scheme's launch in 1993. The greater access to later stage funding in the US may, however, be helping companies there scale up faster - hence the stronger record in job creation. <h4>Mitigating risk</h4> There are risks in investing in entrepreneurial growth companies. These are mitigated by the highly attractive tax benefits of EIS, including generous loss relief, which can be claimed as an income tax deduction. The potential returns of investing in exciting new businesses meanwhile can be attractive - and even more so on an after-tax basis. There are also inheritance tax and capital gains tax benefits too. <h4>Diversification Element</h4> EIS investments can also offer a useful diversification element within portfolios. During February's market upheaval, for example, our portfolio valuations barely flickered because most of the assets are in private equity and so less susceptible to short-term market volatility. What is most exciting about EIS investing at the moment, though, goes back to the UK v US comparison. Last year was a record year for Calculus, in terms of capital raised and businesses opportunities made available to us. We reviewed more than 500 companies, identifying 15 suitable opportunities - in which we were able to invest a total of £30m. These firms included Africa-focused marketing services company, Every1Mobile, whose clients include multi-nationals, NGOs and government departments; Cambridge-based Axol Bioscience, which supplies cell lines for research purposes to pharma companies and research organisations; and chip designer, Blu Wireless, supplying the 5G chip market. These investments illustrate the breadth of entrepreneurial businesses taking root in today's Britain. As highlighted by the government-commissioned Patient Capital Review, there is still much room for improvement in the provision of funding to growing UK companies - not least the need for more capital to support the scale-up of companies that have moved beyond the EIS and VCT stage. With the government focusing more on this issue, we may see Britain move even closer to becoming the entrepreneurial capital of the world. In our experience, many wealthier investors are excited to be part of this growth revolution. It is a virtuous circle where, done well, attractive returns are achieved while ensuring capital is available for the potential champions of tomorrow. Source: <a href="https://www.professionaladviser.com/professional-adviser/opinion/3028872/john-glencross-dont-mourn-the-death-of-asset-backed-eis-schemes">Professional Adviser</a> <a href="https://www.professionaladviser.com/professional-adviser/opinion/3028872/john-glencross-dont-mourn-the-death-of-asset-backed-eis-schemes">Click here</a> to access the full article.

The US is usually seen as offering the global benchmark for innovation but, as John Glencross illustrates, the UK is now trumping the world's largest economy on read more
CEO of Calculus Capital, John Glencross Features on the First Episode of the Adviser Hour
Feb 23, 2018

<h4>John Glencross features on the very first episode of the Adviser Hour <em>The Current Tax-Efficient Landscape</em></h4> <a href="https://webinars.growthinvest.com/archives/episode-1/">The episode</a> welcomed viewers into the realm of tax-efficient investments as episode 1 provided an overview of the tax-efficient investing landscape including the changes that were brought about by the Patient Capital Review, to better channel the true 'spirit' of EIS & VCTs. You are able to watch the panel discussion on demand by <a href="https://webinars.growthinvest.com/archives/episode-1/">clicking here</a>, featuring John Glencross along with guests from GrowthInvest, the EIS Association, Par Equity and Foster Denovo who assessed tax-efficient investment's current landscape. Below you can watch John Glencross's interview with Adviser Hour host Lawrence Gosling: <center><div style="width: 50%; text-align: center;"> <video width="450" height="225" controls="controls"><source src="https://s3.amazonaws.com/growthinvestlivesite/Episodes/Episode1/John+Glencross+Calculus+Capital+-+Episode+1.mp4" type="video/mp4"></video></div></center> To watch the full episode or panel discussion we welcome you to do so by <a href="https://webinars.growthinvest.com/archives/episode-1/">clicking here</a>. To learn more about Calculus Capital's VCT, <a href="https://growthinvest.com/investment-opportunities/vct/calculus-vct/">click here</a>, and feel free to contact the GrowthInvest team with any queries you may have by <a href="mailto:enquiries@growthinvest.com">email</a> or by telephone on 020 7071 3945.

John Glencross features on the very first episode of the Adviser Hour The Current Tax-Efficient Landscape
read more
Calculus Capital Invests in Axol Bioscience
Sep 01, 2017

Calculus Capital invests - a leading EIS and VCT investor, has completed its third deal in two weeks as they invest £2.5m in Cambridge-based Axol Bioscience (Axol), a provider of stem cells. Founded in Cambridge by Dr Yichen Shi together with experienced entrepeneur and 2017 NED of the year, Johnathon Milner. Read the full article <a href="https://www.calculuscapital.com/calculus-capital-invests-2-5m-in-axol-bioscience/">here. </a> Source: <a href="https://www.calculuscapital.com/">Calculus Capital</a>

Calculus Capital invests - a leading EIS and VCT investor, has completed its third deal in two weeks as they invest £2.5m in Cambridge-based Axol Bioscience (A read more
Calculus Capital Invests in Axol Bioscience
Aug 15, 2017

Calculus Capital invests - a leading EIS and VCT investor, has completed its third deal in two weeks as they invest £2.5m in Cambridge-based Axol Bioscience (Axol), a provider of stem cells. Founded in Cambridge by Dr Yichen Shi together with experienced entrepeneur and 2017 NED of the year, Johnathon Milner. Read the full article <a href="https://www.calculuscapital.com/calculus-capital-invests-2-5m-in-axol-bioscience/">here. </a> Source: <a href="https://www.calculuscapital.com/">Calculus Capital</a>

Calculus Capital invests - a leading EIS and VCT investor, has completed its third deal in two weeks as they invest £2.5m in Cambridge-based Axol Bioscience (A read more

Calculus Capital

Manager Summary

Contact Details

SHARE ON

Open Investments

News & Updates

John Glencross features on the very first episode of the Adviser Hour The Current Tax-Efficient Landscape

GET IN TOUCH

Company

Our Services

Information

Legal Info